59283-35-1 Usage
General Description
(1-benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid is a chemical compound with a complex structure that includes a benzyl group, a methoxy group, a methyl group, and an indol-3-yl group attached to an acetic acid molecule. (1-benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid is likely to have a variety of biological activities due to its structure, including potentially acting as a ligand for various receptors in the body. The presence of the benzyl and methoxy groups suggests that this compound may have some level of lipophilicity, which could affect its distribution and metabolism in the body. The specific biological effects and potential applications of this compound would need to be studied in further detail.
Check Digit Verification of cas no
The CAS Registry Mumber 59283-35-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,2,8 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 59283-35:
(7*5)+(6*9)+(5*2)+(4*8)+(3*3)+(2*3)+(1*5)=151
151 % 10 = 1
So 59283-35-1 is a valid CAS Registry Number.
59283-35-1Relevant articles and documents
Synthesis of amino acid derivatives of indole-3-acetic acid
Liu, Ying,Zhao, Liang,Liu, Liang,Wei, Lin-Yi,Lai, Lu-Hua
, p. 640 - 642 (2007/10/03)
Amino acid derivatives of a modified indole-3-acetic acid have been synthesised. Fourteen new dipeptide-like compounds 3-4 were obtained and their structures were elucidated based on the IR, 1H NMR, MS spectra.
1H-INDOLE-3-ACETAMIDE SPLA2 INHIBITORS
-
, (2008/06/13)
A class of novel 1-indole-3-acetamides represented by the formula; is disclosed together with the use of such indole compounds for inhibiting sPLA2 mediated release of fatty acids.
1H-INDOLE-3-ACETIC ACID HYDRAZIDE SPLA2 INHIBITORS
-
, (2008/06/13)
A class of novel 1H-indole-3-acetic acid hydrazides is disclosed together with the use of such indole compounds for inhibiting sPLA2 mediated release of fatty acids (e.g., arachidonic acid) for treatment of conditions such as septic shock